Investigation of sandwiched gadolinium (III) complexes with tungstosilicates as potential MRI contrast agents

Magnetic Resonance Imaging

Volumn 22, Issue 3, 2004, Pages 421-426

  Sun, Guoying ^a   Feng, Jianghua ^a   Wu, Huifeng ^a   Pei, Fengkui ^a   Fang, Ke ^b   Lei, Hao ^b  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b Wuhan National Laboratory for Optoelectronics   (China)

Author keywords

Contrast agent; Gadolinium; MRI; Relaxivity; Tungstosilicate

Indexed keywords

BOVINE SERUM ALBUMIN; CONTRAST MEDIUM; GADOLINIUM; METAL COMPLEX; SILICATE; TUNGSTEN DERIVATIVE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LETHAL DOSE; LIVER; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; TEMPERATURE DEPENDENCE; TISSUE SPECIFICITY;

ACUTE TOXICITY TESTS; ANIMALS; CONTRAST MEDIA; GADOLINIUM; IMAGE ENHANCEMENT; KIDNEY; LETHAL DOSE 50; LIVER; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, SPRAGUE-DAWLEY; SILICATES; TUNGSTEN COMPOUNDS;

BOVINAE;

EID: 1942484801     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2004.01.014     Document Type: Article

References (26)

1. Rinck PA. Magnetic resonance imaging. 4th ed., Berlin: Blackwell Science, 2001. p. 149.
2. Lauffer R.B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging theory and design. Chem Rev. 87:1987;901-927.
3. Caravan P.J., Ellison J., Mcmurry T.J., Lauffer R.B. Gadolinium (III) chelates as MRI contrast agents structure, dynamics, and applications. Chem Rev. 99:1999;2293-2352.
4. Runge V.M. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging. 44:2000;867-872.
5. Aime S., Frullano L., Crich S.G. Compartmentalization of a gadolinium complex in the apoferritin cavity a route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew Chem Int Ed. 41:2002;1018-1019.
6. Reynolds C.H., Annan N., Beshah K. Gadolinium-loaded nanoparticles new contrast agents for magnetic resonance imaging. J Am Chem Soc. 122:2000;8940-8945.
7. 1-weighted images at two different doses. J Magn Reson Imaging. 10:1999;80-83.
8. Willich H.S., Brehm M., Ewers C.L.J., et al. Synthesis and physicochemical characterization of a new gadolinium chelate the liver-specific magnetic resonance imaging contrast agent Gd-EOB-DTPA. Inorg Chem. 38:1999;1134-1144.
9. Bernardino M.E., Young S.W., Lee J.K., Weinreb J.C. Hepatic MR imaging with Mn-DPDP safety, image quality, and sensitivity. Radiology. 183:1992;53-58.
10. Parmelee D.J., Walovitch R.C., Ouellet H.S., Lauffer R.B. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol. 32:1997;741-747.
11. Lokling K.E., Fossheim S.L., Skurtveit R., Bjornerud A., Klaveness J. pH-sensitive paramagnetic liposomes as MRI contrast agents in vitro feasibility studies. Magn Reson Imaging. 19:2001;731-738.
12. Konda S.D., Aref M., Wang S., Brechbiel M., Wiener E.C. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. MAGMA. 12:2001;104-113.
13. Feng J.H., Li X.J., Pei F.K., Sun G.Y., Zhang X., Liu M.L. An evaluation of gadolinium polyoxometalates as possible MRI contrast agent. Magn Reson Imaging. 20:2002;407-412.
14. Feng J.H., Sun G.Y., Pei F.K., Liu M.L. Comparison between GdDTPA and two gadolinium polyoxometalates as potential MRI contrast agent. J Inorg Biochem. 92:2002;193-199.
15. North EO, Hancy W. Inorg synthesis. vol 2. Booth HS, editor. Gong YS, Translated by Shen PW, translator. Beijing: Science Press, 1959. p. 114.
16. Peacock RD, Weakley TJR. Heteropolytungstate complexes of the lanthanide elements. Part 1 preparation and reactions. J Chem Soc (A) 1971;1836-39.
17. Herve G., Teze A. Study of α- and β-enneatungstosilicates and -germanates. Inorg Chem. 16:1977;2115-2117.
18. 10- (X=Si, Ge). Acta Chim Sin. 55:1997;1077-1083.
19. Li X.Y., Li X.J., Zhang S.R., Pei F.K. NMR relaxation studies of GdDTPA in human serum albumin solution. Polyhedron. 18:1999;695-697.
20. Gilbert J., Kassab D., Pawlow J.H., et al. First characterization of the influence of paramagnetic heteropoly complexes of tungsten on relaxation times of water. Separation of various contributions to relaxivities. Inorg Chem. 34:1995;924-927.
21. Kellar K.E., Foster N. Relaxation enhancement of water protons by manganese (III) porphyrins-influence of porphyrin aggregation. Inorg Chem. 31:1992;1353-1359.
22. Bligh S.W.A., Chowdhury A.H.M.S., Kennedy D., Luchinat C., Parigi G. Non-ionic bulky Gd(III) DTPA-bisamide complexes as potential contrast agents for magnetic resonance imaging. Magn Reson Med. 41:1999;767-773.
23. Fossheim S.L., Kellar K.E., Mansson S. Investigation of lanthanide-based starch particles as a model system for liver contrast agents. J Magn Reson Imaging. 9:1999;295-303.
24. Weinmann H.J., Giampieri G.S., Willich H.S., Vogler H., Frenzel T., Geies H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med. 10:1991;439-444.
25. Okuhata Y. Delivery of diagnostic agents for magnetic resonance imaging. Adv Drug Deliv Rev. 37:1999;121-137.
26. Bradshaw JE, Gillogly KA, Wilson LJ, et al. New non-ionic water-soluble porphyrins: evaluation of manganese (III) polyhydroxylamide porphyrins as MRI contrast agent. Inorg Chim Acta 1998;275-276:106-16.